Fox Hill Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Buy |
683
+6
| +0.9% | +$2.67K | 0.16% | 86 |
|
|
2025
Q1 | $328K | Sell |
677
-1
| -0.1% | -$485 | 0.19% | 79 |
|
|
2024
Q4 | $273K | Sell |
678
-15
| -2% | -$6.04K | 0.15% | 84 |
|
|
2024
Q3 | $322K | Buy |
693
+25
| +4% | +$11.6K | 0.18% | 80 |
|
|
2024
Q2 | $313K | Sell |
668
-19
| -3% | -$8.91K | 0.19% | 74 |
|
|
2024
Q1 | $287K | Buy |
687
+15
| +2% | +$6.27K | 0.19% | 82 |
|
|
2023
Q4 | $273K | Buy |
+672
| New | +$273K | 0.21% | 78 |
|